Viewing Study NCT01825395


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-04-17 @ 1:53 AM
Study NCT ID: NCT01825395
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2021-10-06
First Post: 2013-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Sponsor: University of Colorado, Denver
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2013-03-22
First Submit QC Date: None
Study First Post Date: 2013-04-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-09-28
Last Update Post Date: 2021-10-06
Last Update Post Date Type: ACTUAL